Sanjuán Máñez R, Morell Cabedo S, Ruiz Granell R, Cortina Nicolás J, Ibáñez Candela M, Monmeneu Menadas J V, Blasco Cortés M, García Civera R, Botella Solana S
Unidad Coronaria, Hospital Clínico Universitario, Valencia.
Rev Esp Cardiol. 1996 Jul;49(7):492-500.
Since physiological pacing systems have become available, a debate has raged about the merits of atrial versus ventricular pacing in the sick sinus syndrome. The goal of this retrospective report was to study the long term incidence and the independent predictors for atrial fibrillation and stroke in 153 paced patients with sick sinus syndrome, adjusting for differences in baseline clinical variables with multivariate analysis.
From 1980 to 1994, we implanted 32 dualchamber, 33 atrial, and 88 ventricular pacemakers to treat patients with sick sinus syndrome. After a maximum follow-up of 177 months (median 30 months for paroxismal atrial fibrillation, 45 months for chronic atrial fibrillation and 43,5 months for stroke) the actuarial incidence of paroximal atrial fibrillation was 7.8% at 1 year, 29% at 5 years and 42% at 10 years. The actuarial incidence of chronic atrial fibrillation was 1.3% at 1 year, 9.8% at 5 years and 22% at 10 years. Independent predictors for paroxismal AF from Cox's model was history of atrial tachyarrhythmias (p < 0.0001), chronic obstructive pulmonary disease (p = 0,006) and age (> 70 years-old) (p = 0.035). Only a history of atrial tachyarrhythmias before pacemaker implant was an independent predictor for chronic atrial fibrillation (p < 0.0001). The odd ratio for paroxismal atrial fibrillation in patients with previous atrial tachyarrhythmias and chronic atrial fibrillation were 6 (2.8-12) and 4 (1.6-9.7) (95% confiance limits). Actuarial incidence of stroke was 3% at 1 year, 10% at 5 years and 14% at 10 years. Independent predictors for stroke were history of peripheral vascular disease (p = 0.033) and hypertensive cardiomyopathy (p = 0.015). Development of paroxysmal and chronic atrial fibrillation during the follow-up were higher in patients with stroke (p < 0.001 and p < 0.05).
Development of atrial fibrillation and stroke in paced patients with sick sinus syndrome are strongly determined by clinical variables. Preimplant paroxysmal atrial tachyarrhythmias is the most important predictor for atrial fibrillation in the follow-up.
自从生理性起搏系统问世以来,关于病态窦房结综合征患者心房起搏与心室起搏的优缺点一直争论不休。本回顾性报告的目的是研究153例接受起搏治疗的病态窦房结综合征患者房颤和中风的长期发生率及独立预测因素,并通过多变量分析对基线临床变量的差异进行校正。
1980年至1994年,我们为病态窦房结综合征患者植入了32台双腔起搏器、33台心房起搏器和88台心室起搏器。在最长随访177个月后(阵发性房颤的中位随访时间为30个月,慢性房颤为45个月,中风为43.5个月),阵发性房颤的精算发生率在1年时为7.8%,5年时为29%,10年时为42%。慢性房颤的精算发生率在1年时为1.3%,5年时为9.8%,10年时为22%。Cox模型中阵发性房颤的独立预测因素为房性快速心律失常病史(p<0.0001)、慢性阻塞性肺疾病(p=0.006)和年龄(>70岁)(p=0.035)。只有起搏器植入前的房性快速心律失常病史是慢性房颤的独立预测因素(p<0.0001)。既往有房性快速心律失常和慢性房颤患者发生阵发性房颤的比值比分别为6(2.8-12)和4(1.6-9.7)(95%置信区间)。中风的精算发生率在1年时为3%,5年时为10%,10年时为14%。中风的独立预测因素为外周血管疾病病史(p=0.033)和高血压性心肌病(p=0.015)。随访期间发生阵发性和慢性房颤的情况在中风患者中更高(p<0.001和p<0.05)。
病态窦房结综合征起搏患者房颤和中风的发生很大程度上由临床变量决定。植入前阵发性房性快速心律失常是随访中房颤最重要的预测因素。